Literature DB >> 12080007

Progesterone blocks the estradiol-stimulated luteinizing hormone surge by disrupting activation in response to a stimulatory estradiol signal in the ewe.

T A Richter1, J E Robinson, N P Evans.   

Abstract

The preovulatory surges of GnRH and LH are activated by increased concentrations of circulating estradiol, but ovulation is blocked when progesterone concentrations are elevated. Although it is has been shown that this action of progesterone is due to a central inhibition of the GnRH surge, the mechanisms that underlie the blockade of the GnRH surge are poorly understood. In this study we investigated whether progesterone can block the estradiol-dependent activation stage of the GnRH surge induction process, and thus prevent expression of the LH surge. The results demonstrated that exposure to progesterone for half or the full duration of the activation stage can prevent the stimulation of LH surges by estradiol (experiment 1), whereas exposure to progesterone midway though a period of estradiol exposure, which in itself is sufficient to activate the surge, did not block the LH surge (experiment 2). These results suggest that progesterone 1) disrupts activation of the surge induction system in response to a stimulatory estradiol signal and 2) does not compromise the ability of animals to respond to a stimulatory estradiol signal applied immediately after progesterone exposure. Because the disruptive effects of activated progesterone in response to estradiol are rapid but transient, it may be that progesterone directly interferes with the activation of estradiol-responsive neural systems to block the GnRH/LH surge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080007     DOI: 10.1095/biolreprod67.1.119

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

2.  Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release.

Authors:  Nicole Sleiter; Yefei Pang; Cheryl Park; Teresa H Horton; Jing Dong; Peter Thomas; Jon E Levine
Journal:  Endocrinology       Date:  2009-05-07       Impact factor: 4.736

3.  Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  Xiuxian Zhu; Xiaole Zhang; Yonglun Fu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats.

Authors:  Wen He; Xiaofeng Li; Daniel Adekunbi; Yali Liu; Hui Long; Li Wang; Qifeng Lyu; Yanping Kuang; Kevin T O'Byrne
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

5.  Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial.

Authors:  Joaquín Llácer; Belén Moliner; Lydia Luque; Andrea Bernabéu; Belén Lledó; Juan Carlos Castillo; Jaime Guerrero; Jorge Ten; Rafael Bernabéu
Journal:  Reprod Biol Endocrinol       Date:  2020-02-07       Impact factor: 5.211

6.  Comparison of the effects of Duphaston and Cetrotide on oocyte and embryo quality in women undergoing ICSI: A cross-sectional study.

Authors:  Niloofar Motaref; Sheyda Jouhari; Afsaneh Mohammadzadeh; Somaieh Kazemnejad; Narges Madadi; Sadaf Eghtedari; Abolfazl Ghoodjani
Journal:  Int J Reprod Biomed       Date:  2020-11-22

7.  Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.

Authors:  Yun Wang; Qiuju Chen; NingLing Wang; Hong Chen; Qifeng Lyu; Yanping Kuang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.